Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Dublin-based investor in life sciences companies - Reports intrinsic equity value of EUR6.44 at June 30 half-year end, ...
Dublin-based investor in life sciences companies - Investee company Poseida Therapeutics Inc enters into a research co ...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Dublin-based investor in life sciences companies - Confirms that Fiona Dunlevy joins the board as an executive directo ...
The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...
Malin Corp PLC said that its Chief Executive Officer Darragh Lyons will resign from his position before the end of 20 ...
Amended the initial Purchase Agreement to effectuate the first step of the transaction Transaction expected to officially close in the third quarter of 2023 TORONTO, May 02, 2023 (GLOBE...
Increased Total Revenue in both the Asset Management and Insurance Segments, Increased Fee Related Earnings, Signed an Agreement for an Additional Acquisition following Year-End 2022 Declares...
Malin Corp PLC on Tuesday said it will return EUR140 million to shareholders, through a tender offer. In February, t ...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
